AVEX enters the back half of September with an awkward split: a fresh analyst endorsement from Jefferies landing the same day the stock trades near a one-month low, while short sellers have quietly built one of their most aggressive positions of the year.
The short-side story is the clearest signal worth tracking. Estimated short interest has climbed 33% over the past month, reaching roughly 5 million shares, with the pace of accumulation sharpest in the past week — up nearly 11% in five trading sessions. The borrow market has tightened in response. Availability has compressed from a relatively loose 156% of short interest in late August to just 68% today, its tightest reading of the past 52 weeks, meaning the pool of shares available to borrow has nearly halved relative to the short interest outstanding. Cost to borrow, while still low in absolute terms at 1.09%, has risen 43% over the past month — a signal that borrow demand is growing faster than supply. The ORTEX short score backs this up, sitting at 68.9 and up from 64.6 earlier this month — a gradual but consistent grind higher that reflects building bearish pressure.
Options traders, by contrast, tell a more bullish story. The put/call ratio has dropped to 0.34, nearly three standard deviations below its 20-day average — the most call-skewed reading in recent memory, and within touching distance of the 52-week low. That positioning is unusual alongside a stock down 13% over the past month and 3.7% in the prior session alone. Either options buyers are fading the short-side thesis aggressively, or call activity has been driven by something more technical. Either way, the divergence between short positioning and options sentiment is the clearest tension in the setup this week.
The Street is broadly constructive, though the range of views is wide. Jefferies' Sheila Kahyaoglu reinstated coverage this morning with a Buy and a $26 target — notable as a recent bellwether move, though it implies roughly 64% upside from the current $15.90, and sits well below Needham's $45 target, which has been held since the stock's May IPO-era coverage initiation. JP Morgan maintained Overweight with a $35 target in May. Piper Sandler was the lone skeptic at initiation, starting at Neutral with a $20 target in early September. The consensus mean of roughly $33 implies over 100% return potential from current levels — an unusually wide gap that reflects both the stock's post-IPO slide and genuine disagreement on execution risk. Valuation multiples have compressed hard: the P/E ratio has fallen by 14 turns over the past month, and EV/EBITDA has dropped nearly two full turns, leaving the stock at 22x trailing earnings and 8.4x EBITDA — multiples that bulls argue price in a lot of bad news.
The ownership structure gives the short thesis some obvious context. Madison Dearborn Partners, which filed a Schedule 13G disclosing a 49.5% passive stake in August, sold 2.27 million shares at $25.99 in June — a $59 million disposal at prices well above where the stock trades today. AEVEX is a recent listing with a concentrated register: Razor's Edge Fund III holds 18.4% (filed 13G on September 15), Fidelity National Financial holds 5.2%, and the top five holders control roughly 85% of the company. With that much stock in a small number of hands and a large-cap private equity backer having already sold near the highs, the overhang question is live. Insider data through June 5 showed net disposals of roughly 57.6 million in value — all pre-arranged distributions and transfers rather than open-market sales, which limits the read-through, but the directionality isn't encouraging.
Earnings history adds another layer of caution. The most recent print, in August, sent the stock down 5.7% the next day and nearly 15% over the following five sessions — the kind of post-result drift that tends to attract fresh short positioning. The next earnings event is pencilled in for November 12. Between now and then, the key dynamic to watch is whether availability continues to tighten toward zero — if it does, the cost of maintaining short positions will rise sharply — or whether the Jefferies reinstatement and the call-heavy options market catalyse enough buying interest to force some short cover before results.
See the live data behind this article on ORTEX.
Open AVEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
